L
Liminatus Pharma, Inc. (LIMN)
NGM – Real vaqt narxi. Valyuta: USD
0.11
+0.01 (6.77%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.10
-0.01 (-5.39%)
Bozordan keyin: Jun 26, 2026, 7:31 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
0.11
+0.01 (6.77%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.10
-0.01 (-5.39%)
Bozordan keyin: Jun 26, 2026, 7:31 PM EDT
Liminatus Pharma, Inc., preclinical bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonni davolash usullarini ishlab chiqish bilan shug'ullanadi. U ilg'or qattiq o'smalar, shu jumladan mayda hujayrali o'pka saratonini davolash uchun I bosqich klinik sinovida bo'lgan insonlashtirilgan anti CD47 monoklonal antitelasi bo'lgan IBA101ni ishlab chiqadi. Kompaniya 2018 yilda tashkil etilgan va Kaliforniyaning Serritos shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Beom Kyu Choi | Chief Technology Officer & Member of Scientific Advisory Board |
| Dr. Byong Chul Yoo Ph.D. | Chief Science Officer & Member of Scientific Advisory Board |
| Dr. Sang-jin Lee Ph.D. | Head of Research & Development and Member of Scientific Advisory Board |
| Mr. Chris Kim J.D., L.L.M. | CEO & Chairman |
| Mr. Scott Dam | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-24 | S-1 | limn-20260331xs1.htm |
| 2026-06-18 | D | |
| 2026-06-03 | 8-K | tm2616851d1_8k.htm |
| 2026-05-27 | 8-K | tm2615785d1_8k.htm |
| 2026-05-20 | 8-K | tm2615228d1_8k.htm |
| 2026-05-15 | 10-Q | limn-20260331x10q.htm |
| 2026-03-31 | 10-K | limn-20251231x10k.htm |
| 2026-03-04 | 8-K | tm267974d1_8k.htm |
| 2026-02-18 | 8-K | tm266571d1_8k.htm |
| 2026-02-11 | S-1 | limn-20250930xs1.htm |